Prof. David Tougeron provides the GI cancer highlights from ESMO 2020. Watch the video and download the slides.
Prof. David Tougeron provides the GI cancer highlights from ESMO 2020. Watch the video and download the slides.
Dr David Tougeron is a professor of gastroenterology at Poitiers University Hospital, France. His clinical interests focus on gastrointestinal cancers, in particular, colorectal cancer. Dr Tougeron has participated in more than 40 clinical trials in digestive oncology and has co-authored more than 50 articles, editorials and book chapters. After a Ph.D. in immune response in colorectal cancer, Dr Tougeron completed a postdoctoral position at the Mayo Clinic, U.S., in colorectal cancer chemosensitivity. His research is currently focussing on colorectal cancer, particularly colorectal cancer with microsatellite instability and predictive biomarkers of response to targeted therapies. He presently holds professional positions in different organisations, notably the Fédération Francophone de Cancérologie Digestive (FFCD).
Amgen, AstraZeneca, Bayer, BMS, Merck Serono, MSD, Pierre Fabre, Roche, Sanofi and Servier.
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Maximising outcomes for patients with advanced RCC
Medical experts make recommendations for best practice
The latest non-small cell lung cancer data presented at ASCO
GI oncologists review the latest data presented at ASCO 2024
Medical experts discuss the latest learnings from clinical practice